Nature Medicine, Published online: 15 July 2025; doi:10.1038/s41591-025-03807-3
A new Global Neurodegeneration Proteomics Consortium provides a wealth of data to boost mechanistic understanding, biomarker research and drug development during aging and in neurodegenerative diseases — and dementia in particular.
